{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:46:05Z","timestamp":1793393165027,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030875","name":"Balgrist University Hospital","doi-asserted-by":"crossref","award":["W955"],"award-info":[{"award-number":["W955"]}],"id":[{"id":"10.13039\/100030875","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The perioperative antibiotic prophylaxis with 1st or 2nd generation cephalosporins is evidence-based in orthopedic surgery. There are, however, situations with a high risk of prophylaxis-resistant surgical site infections (SSI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We perform a superiority randomized controlled trial with a 10% margin and a power of 90% in favor of the broad-spectrum prophylaxis. We will randomize orthopedic interventions with a high risk for SSI due to selection of resistant pathogens (open fractures, surgery under therapeutic antibiotics, orthopedic tumor surgery, spine surgery with American Society of Anesthesiologists (ASA) score \u2265 3 points) in a prospective-alternating scheme (1:1, standard prophylaxis with cefuroxime versus a broad-spectrum prophylaxis of a combined single-shot of vancomycin 1 g and gentamicin 5 mg\/kg parenterally). The primary outcome is \u201cremission\u201d at 6 weeks for most orthopedic surgeries or at 1 year for surgeries with implant. Secondary outcomes are the risk for prophylaxis-resistant SSI pathogens, revision surgery for any reason, change of antibiotic therapy during the treatment of infection, adverse events, and the postoperative healthcare-associated infections other than SSI within 6 weeks (e.g., urine infections or pneumonia). With event-free surgeries to 95% in the broad-spectrum versus 85% in the standard prophylaxis arm, we need 2 \u00d7 207 orthopedic surgeries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In selected patients with a high risk for infections due to selection of prophylaxis-resistant SSI, a broad-spectrum combination with vancomycin and gentamycin might prevent SSIs (and other postoperative infections) better than the prophylaxis with cefuroxime.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrial.gov NCT05502380. Registered on 12 August 2022.\u00a0Protocol version: 2 (3 June 2022)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07605-5","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T08:02:17Z","timestamp":1705651337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Broad-spectrum antibiotic prophylaxis in tumor and infected orthopedic surgery\u2014the prospective-randomized, microbiologist-blinded, stratified, superiority trials: BAPTIST Trials"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5552-0973","authenticated-orcid":false,"given":"Ilker","family":"U\u00e7kay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen","family":"Bomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Risch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazda","family":"Farshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"7605_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jhin.2012.12.014","volume":"84","author":"I U\u00e7kay","year":"2013","unstructured":"U\u00e7kay I, Hoffmeyer P, Lew D, Pittet D. Prevention of surgical site infections in orthopaedic surgery and bone trauma: state-of-the-art update. J Hosp Infect. 2013;84:5\u201312.","journal-title":"J Hosp Infect"},{"key":"7605_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ijid.2021.06.008","volume":"108","author":"A Hasler","year":"2021","unstructured":"Hasler A, Unterfrauner I, Olthof MGL, Jans P, Betz M, Achermann Y, U\u00e7kay I. Deep surgical site infections following double-dose perioperative antibiotic prophylaxis in adult obese orthopedic patients. Int J Infect Dis. 2021;108:537\u201342.","journal-title":"Int J Infect Dis"},{"key":"7605_CR3","doi-asserted-by":"publisher","first-page":"0226674","DOI":"10.1371\/journal.pone.0226674","volume":"14","author":"L Wuarin","year":"2019","unstructured":"Wuarin L, Abbas M, Harbarth S, Waibel FAW, Holy D, Burkhard J, et al. Changing perioperative prophylaxis during antibiotic therapy and iterative debridement for orthopedic infections? PLoS One. 2019;14:0226674.","journal-title":"PLoS One"},{"key":"7605_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13756-018-0421-2","volume":"7","author":"M Davat","year":"2018","unstructured":"Davat M, Wuarin L, Stafylakis D, Abbas M, Harbarth S, Hannouche D, et al. Should antibiotic prophylaxis before orthopedic implant surgery depend on the duration of pre-surgical hospital stay? Antimicrob Resist Infect Control. 2018;7:131.","journal-title":"Antimicrob Resist Infect Control"},{"key":"7605_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7150\/jbji.17171","volume":"2","author":"O Jamei","year":"2017","unstructured":"Jamei O, Gjoni S, Zenelaj B, Kressmann B, Belaieff W, Hannouche D, et al. Which orthopaedic patients are infected with Gram-negative non-fermenting rods? J Bone Jt Infect. 2017;2:73\u20136.","journal-title":"J Bone Jt Infect"},{"key":"7605_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jhin.2011.06.014","volume":"79","author":"I U\u00e7kay","year":"2011","unstructured":"U\u00e7kay I, Harbarth S, Ferry T, L\u00fcbbeke A, Emonet S, Hoffmeyer P, et al. Meticillin resistance in orthopaedic coagulase-negative staphylococcal infections. J Hosp Infect. 2011;79:248\u201353.","journal-title":"J Hosp Infect"},{"issue":"5","key":"7605_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jamcollsurg.2017.08.010","volume":"225","author":"ME Cohen","year":"2017","unstructured":"Cohen ME, Salmasian H, Li J, Liu J, Zachariah P, Wright JD, et al. Surgical antibiotic prophylaxis and risk for postoperative antibiotic-resistant infections. J Am Coll Surg. 2017;225(5):631-8 e3.","journal-title":"J Am Coll Surg"},{"key":"7605_CR8","doi-asserted-by":"publisher","first-page":"254263","DOI":"10.7150\/jbji.39050","volume":"4","author":"D M\u00fcller","year":"2019","unstructured":"M\u00fcller D, Kaiser D, Sairanen K, Studhalter T, U\u00e7kay I. Antimicrobial prophylaxis for the prevention of surgical site infections in orthopaedic oncology - a narrative review of current concepts. J Bone Jt Infect. 2019;4:254263.","journal-title":"J Bone Jt Infect"},{"key":"7605_CR9","first-page":"2443","volume":"4","author":"T Rod-Fleury","year":"2019","unstructured":"Rod-Fleury T, U\u00e7kay I. Microbiological particularities of surgical site infections in oncologic orthopedic surgery compared to non - oncologic surgery-single center experience and literature review. Clin Surg. 2019;4:2443.","journal-title":"Clin Surg"},{"key":"7605_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1302\/0301-620X.95B6.30114","volume":"95-B","author":"N Dunkel","year":"2013","unstructured":"Dunkel N, Pittet D, Tovmirzaeva L, Suv\u00e0 D, Bernard L, Lew D, et al. Short duration of antibiotic prophylaxis in open fractures does not enhance risk of subsequent infection. Bone Joint J. 2013;95-B:831\u20137.","journal-title":"Bone Joint J"},{"key":"7605_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00268-011-0993-y","volume":"35","author":"I U\u00e7kay","year":"2011","unstructured":"U\u00e7kay I, Agostinho A, Belaieff W, Toutous-Trellu L, Scherer-Pietramaggiori S, Andres A, et al. Noninfectious wound complications in clean surgery: epidemiology, risk factors, and association with antibiotic use. World J Surg. 2011;35:973\u201380.","journal-title":"World J Surg"},{"key":"7605_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/14787210.2020.1730177","volume":"18","author":"B Ertu\u011frul","year":"2020","unstructured":"Ertu\u011frul B, U\u00e7kay I, Sch\u00f6ni M, Peter-Riesch B, Lipsky BA. Management of diabetic foot infections in the light of recent literature and new international guidelines. Expert Rev Anti Infect Ther. 2020;18:293\u2013305.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"7605_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jinf.2015.08.002","volume":"71","author":"M Al-Mayahi","year":"2015","unstructured":"Al-Mayahi M, Cian A, Lipsky BA, Suv\u00e0 D, M\u00fcller C, Landelle C, et al. Administration of antibiotic agents before intraoperative sampling in orthopedic infections alters culture results. J Infect. 2015;71:518\u201325.","journal-title":"J Infect"},{"key":"7605_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1742-481X.2011.00773.x","volume":"8","author":"S Karaca","year":"2011","unstructured":"Karaca S, \u04aaikirikcio\u011flu M, U\u00e7kay I, Afksendyios K. Comparison of vacuum-assisted closure device and conservative treatment for fasciotomy wound healing in ischemia-reperfusion syndrome: preliminary results. Int Wound J. 2011;8:229\u201336.","journal-title":"Int Wound J"},{"key":"7605_CR15","doi-asserted-by":"publisher","first-page":"205031211877395","DOI":"10.1177\/2050312118773950","volume":"6","author":"I U\u00e7kay","year":"2018","unstructured":"U\u00e7kay I, Kressmann B, Di Tommaso S, Portela M, Alwan H, Vuagnat H, et al. A randomized controlled trial of the safety and efficacy of a topical gentamicin-collagen sponge in diabetic patients with a mild foot ulcer infection. SAGE Open Med. 2018;6:2050312118773950.","journal-title":"SAGE Open Med"},{"key":"7605_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12879-018-3253-z","volume":"18","author":"I U\u00e7kay","year":"2018","unstructured":"U\u00e7kay I, Kressmann B, Malacarne S, Toumanova A, Jaafar J, Lew D, et al. A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection. BMC Infect Dis. 2018;18:361.","journal-title":"BMC Infect Dis"},{"key":"7605_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2106\/00004623-200704000-00026","volume":"89","author":"Q Cui","year":"2007","unstructured":"Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89:871\u201382.","journal-title":"J Bone Joint Surg Am"},{"key":"7605_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1086\/501620","volume":"20","author":"AJ Mangram","year":"1999","unstructured":"Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20:250\u201378.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7605_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000142729","volume":"82","author":"L Vauthey","year":"2008","unstructured":"Vauthey L, U\u00e7kay I, Abrassart S, Bernard L, Assal M, Ferry T, et al. Vancomycin-induced DRESS syndrome in a female patient. Pharmacology. 2008;82:138\u201341.","journal-title":"Pharmacology"},{"key":"7605_CR20","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","volume":"101","author":"S Harbarth","year":"2000","unstructured":"Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101:2916\u201321.","journal-title":"Circulation"},{"key":"7605_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710\u20138.","journal-title":"Am J Epidemiol"},{"key":"7605_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/2193-1801-2-91","volume":"2","author":"A Agostinho","year":"2013","unstructured":"Agostinho A, Renzi G, Haustein T, Jourdan G, Bonfillon C, Rougemont M, et al. Epidemiology and acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a septic orthopedic ward. SpringerPlus. 2013;2:91.","journal-title":"SpringerPlus"},{"key":"7605_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1089\/sur.2020.300","volume":"22","author":"T McMurtrie","year":"2021","unstructured":"McMurtrie T, Prather J, Cone R, Montgomery T, Patel C, McGwin G, et al. Extended antibiotic coverage in the management of type II open fractures. Surg Infect (Larchmt). 2021;22:662\u20137.","journal-title":"Surg Infect (Larchmt)"},{"key":"7605_CR24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/BOT.0b013e31828d92ee","volume":"27","author":"CC Saveli","year":"2013","unstructured":"Saveli CC, Morgan SJ, Belknap RW, Ross E, Stahel PF, Chaus GW, et al. Prophylactic antibiotics in open fractures: a pilot randomized clinical safety study. J Orthop Trauma. 2013;27:552\u20137.","journal-title":"J Orthop Trauma"},{"key":"7605_CR25","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00264-014-2395-x","volume":"38","author":"A Gonzalez","year":"2014","unstructured":"Gonzalez A, Suv\u00e0 D, Dunkel N, Nicod\u00e8me JD, Lomessy A, Lauper N, et al. Are there clinical variables determining antibiotic prophylaxis-susceptible versus resistant infection in open fractures? Int Orthop. 2014;38:2323\u20137.","journal-title":"Int Orthop"},{"key":"7605_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/BOT.0000000000000554","volume":"30","author":"J Redfern","year":"2016","unstructured":"Redfern J, Wasilko SM, Groth ME, McMillian WD, Bartlett CS 3rd. Surgical site infections in patients with type 3 open fractures: comparing antibiotic prophylaxis with cefazolin plus gentamicin versus piperacillin\/tazobactam. J Orthop Trauma. 2016;30:415\u20139.","journal-title":"J Orthop Trauma"},{"key":"7605_CR27","doi-asserted-by":"publisher","first-page":"1002340","DOI":"10.1371\/journal.pmed.1002340","volume":"14","author":"W Branch-Elliman","year":"2017","unstructured":"Branch-Elliman W, Ripollone JE, O\u2019Brien WJ, Itani KMF, Schweizer ML, Perencevich E, et al. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: a national propensity-score-adjusted retrospective cohort study. PLoS Med. 2017;14:1002340.","journal-title":"PLoS Med"},{"key":"7605_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/SLA.0b013e318202fda9","volume":"253","author":"H Sax","year":"2011","unstructured":"Sax H, U\u00e7kay I, Balmelli C, Bernasconi E, Boubaker K, M\u00fchlemann K, et al. Overall burden of healthcare-associated infections among surgical patients. Results of a national study. Ann Surg. 2011;253:365\u201370.","journal-title":"Ann Surg."},{"key":"7605_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2047-2994-2-5","volume":"2","author":"I U\u00e7kay","year":"2013","unstructured":"U\u00e7kay I, Sax H, Gayet-Ag\u00e9ron A, Ruef C, M\u00fchlemann K, Troillet N, et al. High proportion of healthcare-associated urinary tract infection in the absence of prior exposure to urinary catheter: a cross-sectional study. Antimicrob Resist Infect Control. 2013;2:5.","journal-title":"Antimicrob Resist Infect Control"},{"key":"7605_CR30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/BRS.0b013e3182a42a68","volume":"38","author":"A Abdul-Jabbar","year":"2013","unstructured":"Abdul-Jabbar A, Berven SH, Hu SS, Chou D, Mummaneni PV, Takemoto S, et al. Surgical site infections in spine surgery: identification of microbiologic and surgical characteristics in 239 cases. Spine (Phila Pa 1976). 2013;38:1425\u201331.","journal-title":"Spine (Phila Pa 1976)"},{"key":"7605_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.wneu.2018.11.169","volume":"123","author":"JW Yoon","year":"2019","unstructured":"Yoon JW, Wanderman NR, Kerezoudis P, Alvi MA, De Biase G, Akinduro OO, et al. Enterobacter infection after spine surgery: an institutional experience. World Neurosurg. 2019;123:330\u20137.","journal-title":"World Neurosurg"},{"key":"7605_CR32","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.spinee.2019.01.002","volume":"19","author":"A Gande","year":"2019","unstructured":"Gande A, Rosinski A, Cunningham T, Bhatia N, Lee YP. Selection pressures of vancomycin powder use in spine surgery: a meta-analysis. Spine J. 2019;19:1076\u201384.","journal-title":"Spine J"},{"key":"7605_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/antibiotics8040156","volume":"8","author":"AN Oli","year":"2019","unstructured":"Oli AN, Itumo CJ, Okam PC, Ezebialu IU, Okeke KN, Ifezulike CC, et al. Carbapenem-resistant Enterobacteriaceae posing a dilemma in effective healthcare delivery. Antibiotics (Basel). 2019;8:156.","journal-title":"Antibiotics (Basel)"},{"key":"7605_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijantimicag.2012.09.016","volume":"41","author":"F Valour","year":"2013","unstructured":"Valour F, Dutronc H, Dinh A, Cazorla C, Pav\u00e8se P, Lesens O, et al. Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin. Int J Antimicrob Agents. 2013;41:197\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"7605_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11096-017-0576-6","volume":"40","author":"X Li","year":"2018","unstructured":"Li X, Chen H, Zhu S, Liu Y, Yang J, Yuan Z, et al. Efficacy and feasibility of a collaborative multidisciplinary program for antibiotic prophylaxis in clean wound surgery. Int J Clin Pharm. 2018;40:150\u20139.","journal-title":"Int J Clin Pharm"},{"key":"7605_CR36","first-page":"253","volume":"11","author":"J W\u00f3jkowska-Mach","year":"2009","unstructured":"W\u00f3jkowska-Mach J, Bulanda M, Jaje E, Romaniszyn D, Zi\u00f3\u0142kowski G, Fra\u0144czuk B, et al. The risk related to surgical site infections after hip endoarthroplasty-surveillance outcome analysis in two Polish orthopaedic centres. Ortop Traumatol Rehabil. 2009;11:253\u201363.","journal-title":"Ortop Traumatol Rehabil"},{"key":"7605_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/ijmm.IJMM_20_284","volume":"38","author":"S Shah","year":"2020","unstructured":"Shah S, Singhal T, Naik R, Thakkar P. Predominance of multidrug-resistant Gram-negative organisms as cause of surgical site infections at a private tertiary care hospital in Mumbai India. Indian J Med Microbiol. 2020;38:344\u201350.","journal-title":"Indian J Med Microbiol"},{"key":"7605_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13063-022-06316-7","volume":"23","author":"R Qureshi","year":"2022","unstructured":"Qureshi R, Gough A, Loudon K. The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors. Trials. 2022;23:359.","journal-title":"Trials"},{"key":"7605_CR39","doi-asserted-by":"publisher","first-page":"7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A Chan","year":"2013","unstructured":"Chan A, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:7586.","journal-title":"BMJ"},{"key":"7605_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13063-016-1743-0","volume":"18","author":"T Li","year":"2017","unstructured":"Li T, Boutron I, Al-Shahi Salman R, Cobo E, Flemyng E, et al. Review and publication of protocol submissions to Trials - what have we learned in 10 years? Trials. 2017;18:34.","journal-title":"Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07605-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07605-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07605-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T08:11:45Z","timestamp":1705651905000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07605-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7605"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07605-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2209767\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol is approved by the Cantonal Ethical Commission of Zurich, Stampfenbachstrasse 121, 8090 Z\u00fcrich, Switzerland.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The investigators distribute a written informed consent form to the participants and inform them orally.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}